secwatch.observer — SEC 8-K summary
======================================

Issuer:     Canopy Growth Corp (CGC)
CIK:        0001737927
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0000950170-25-015847
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Canopy Growth Reports Q3 FY2025 Results: Revenue Down 5%, Adjusted EBITDA Improves 61%
--------------------------------------------------------------------------------

- Net revenue was $74.8M, down 5% YoY but up 8% excluding divestitures.
- Canada medical cannabis net revenue rose 16% to $19.6M; Storz & Bickel revenue up 19% to $22M.
- Adjusted EBITDA loss improved 61% to $3.5M; net loss from continuing operations was $121.9M.
- Total debt reduced to $442M from $554M at September 30, 2024, after early term loan prepayment.
- Claybourne infused pre-rolls launched in Canada, reaching #3 market share in BC and Ontario within 6 weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737927/000095017025015847/0000950170-25-015847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737927/000095017025015847/cgc-20250207.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-015847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer